HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

188Re 4- hexadecy- 2,2,9,9- tetramethyl- 4,7- diaza- 1,10- decanedithiol

structure in first source

Also Known As:

(188)Re-HDD; 188Re-4-hexadecyl-4,7-diaza-1,10-decanedithioacetate; 188Re-HDD

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - 188Re 4-hexadecy-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol: 2

Experts

1.	Chung, Jin Wook: 1 article (12/2003)
2.	Chung, June-Key: 1 article (12/2003)
3.	Jeong, Jae Min: 1 article (12/2003)
4.	Lee, Myung Chul: 1 article (12/2003)
5.	Lee, Yun-Sang: 1 article (12/2003)
6.	Paeng, Jin Chul: 1 article (12/2003)
7.	Park, Jae Hyung: 1 article (12/2003)
8.	Son, Miwon: 1 article (12/2003)
9.	Suh, Young-Ger: 1 article (12/2003)
10.	Yoon, Chang Jin: 1 article (12/2003)

Related Diseases

1.	Liver Neoplasms (Liver Cancer) 12/01/2003 - "Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model." 03/01/2002 - "Among the synthesized compounds, the lipiodol solution of 188Re-HDD, the DD derivative with the longest side chain (C16), is a promising agent for therapy of liver cancer."
2.	Neoplasms (Cancer) 12/01/2003 - "The required radioactivity for 100 Gy of irradiation to 2.64- to 5.27-cm tumors was 142-1,070 MBq of (188)Re-HDD in the rabbit model. " 12/01/2003 - "From these images, tumor retention was calculated and compared between (188)Re-TDD and (188)Re-HDD. "

Related Drugs and Biologics

1.	Solutions
2.	Ethiodized Oil (Ethiodol)

Related Therapies and Procedures

1.	Therapeutics